New Clinical Practice: Peripheral Artery Disease in the Legs 👉 nej.md/4sZujsh
Peripheral artery disease affects approximately 236 million persons worldwide and is diagnosed with an ankle–brachial index of less than 0.90. Among older persons, 3.3% of those without peripheral artery disease, 18.1% with mild disease, and 52.0% with severe disease could not complete a 6-minute walk test without resting. To prevent cardiovascular events in persons with peripheral artery disease, intensive cholesterol-lowering medications (statins), antiplatelet medications or low-dose aspirin with rivaroxaban, blood-pressure lowering to less than 130/80 mm Hg, and semaglutide are recommended, along with sodium–glucose cotransporter 2 inhibitors in patients with diabetes. Supervised walking exercise and structured home-based walking exercise each improve walking ability in persons with peripheral artery disease. Revascularization in the legs should be reserved for those with persistent disease symptoms that do not respond to exercise.
Learn more in the Clinical Practice article “Peripheral Artery Disease in the Legs” by Mary M. McDermott, MD, from the Northwestern University Feinberg School of Medicine (@NUFeinbergMed): nej.md/4sZujsh
Meta-analysis of four randomized trials found β-blockers did not reduce mortality, recurrent #MyocardialInfarction (MI), heart failure, or revascularization in patients with preserved left ventricular ejection fraction after MI. ja.ma/3Nv7DQn
President Trump is taking 325 mg of aspirin a day to prevent heart disease. His doctors advise him to take 81 mg. Both are wrong. Here’s why.
New edition of Ground Truths, open-access
erictopol.substack.com/p/the-lowdown-…
The hyperacute T wave (HATW) score is the first objective definition of HATW showing significant clinical utility as an #ECG finding of acute coronary occlusion in potential acute coronary syndrome patients. jacc.org/doi/10.1016/j.…#JACCAdvances#cvACS#STEMI@PendellM
🔴Anticoagulation comparison chart
🔹Apixaban, Rivaroxaban, dabigatran, and warfarin ! Looking for a quick & convenient way to compare different #DOACs & #warfarin?! Look no further than NATF's #anticoagulation comparison chart! See the full chart at hubs.la/Q01vTd1y0
I got called an idiot in front of 4 other med students for calling this an MI…
I still believe this is going to be a LAD-D1 occlusion. I wont find out for a few days…
What are your thoughts?
#ECG#ECGChallenge#Medstudent